{"url_path":"/sec/vbio/8-k/2026-05-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1787740/0001437749-26-017082-index.html","accession_number":"0001437749-26-017082","cik":"0001787740","ticker":"VBIO","issuer_name":"Valion Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1787740/0001437749-26-017082-index.html","primary_entity_key":"0001787740","primary_entity_name":"Valion Bio, Inc."},"word_count":82,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n \n\n \n\n(d)\n\nExhibits.\n\n \n\nExhibit\n\nNo.\n\n \n\nDescription\n\n \n\n \n\n[99.1](ex_941939.htm)\n\n \n\n[Press Release, dated May 14, 2026.](ex_941939.htm)\n\n104\n\n \n\nCover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101).\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n \n \n**VALION BIO, INC.**\n\n \n \n \n \n\nDate:\n\nMay 14, 2026\n\nBy:\n\n/s/ Lisa Wolf\n\n \n \n \n\nName: Lisa Wolf\n\nTitle: Chief Financial Officer"}